Citigroup Inc. Grows Stock Position in HCA Healthcare, Inc. $HCA

Citigroup Inc. lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 9.6% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 207,891 shares of the company’s stock after acquiring an additional 18,131 shares during the quarter. Citigroup Inc. owned approximately 0.09% of HCA Healthcare worth $88,603,000 at the end of the most recent quarter.

Other hedge funds have also bought and sold shares of the company. Clearstead Trust LLC increased its holdings in shares of HCA Healthcare by 311.8% in the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after purchasing an additional 53 shares during the period. Harbor Capital Advisors Inc. boosted its position in shares of HCA Healthcare by 82.9% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after acquiring an additional 34 shares during the last quarter. Twin Peaks Wealth Advisors LLC bought a new position in HCA Healthcare in the second quarter valued at $40,000. Compound Global Advisors LLC bought a new position in shares of HCA Healthcare during the 3rd quarter valued at $44,000. Finally, True Wealth Design LLC boosted its position in HCA Healthcare by 179.5% during the third quarter. True Wealth Design LLC now owns 109 shares of the company’s stock valued at $47,000 after buying an additional 70 shares during the period. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several equities research analysts recently weighed in on HCA shares. Argus increased their target price on HCA Healthcare from $530.00 to $560.00 and gave the company a “buy” rating in a report on Friday, February 6th. Leerink Partners boosted their price objective on shares of HCA Healthcare from $507.00 to $573.00 and gave the company an “outperform” rating in a research report on Wednesday, January 28th. TD Cowen reiterated a “buy” rating on shares of HCA Healthcare in a research report on Wednesday, January 28th. Oppenheimer lifted their price objective on HCA Healthcare from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Wednesday, January 28th. Finally, Cantor Fitzgerald lifted their target price on shares of HCA Healthcare from $525.00 to $588.00 and gave the company an “overweight” rating in a report on Wednesday, January 28th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $530.77.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA is expanding emergency access through local partnerships and new freestanding ERs, which can increase lower‑acuity, higher‑margin volumes and outpatient revenue. Read More.
• Positive Sentiment: HCA opened a new ER site (Shoppes at Mission Trace) — incremental access points support ambulatory/ER growth. Read More.
• Positive Sentiment: Analyst and momentum coverage is favorable: Zacks highlights HCA as a momentum name and JPMorgan raised its price target to $535 (neutral rating but higher target), both of which can attract investor flows. Read More. — Read More.
• Neutral Sentiment: Local human‑interest/community health stories (neonatal success, suicide‑prevention grant) are positive for brand but unlikely to move the stock materially. Read More. — Read More.
• Neutral Sentiment: Leadership moves (new chief nurse in Houston; four new leaders in Alaska) are operational/clinic-level changes that support execution but are not major catalysts on their own. Read More. — Read More.
• Negative Sentiment: A nurse sued HCA Florida Palms West Hospital and a security company after a violent patient attack — litigation and safety concerns can raise reputational risk and potential costs. Read More.
• Negative Sentiment: Critical opinion pieces highlight continued safety concerns at Mission Hospital; sustained negative media about safety can pressure sentiment and invite regulatory/survey scrutiny. Read More.
• Negative Sentiment: Insider selling disclosed: EVP Michael McAlevey sold ~1,694 shares (~$903K). While single insider sales often reflect personal liquidity, markets sometimes view such moves as a minor negative signal. Read More.

Insider Buying and Selling

In other news, EVP Michael S. Cuffe sold 1,500 shares of the stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total value of $747,135.00. Following the sale, the executive vice president directly owned 30,003 shares in the company, valued at approximately $14,944,194.27. This represents a 4.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Christopher F. Wyatt sold 4,000 shares of the business’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the completion of the sale, the senior vice president directly owned 44,379 shares of the company’s stock, valued at approximately $22,411,395. This trade represents a 8.27% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders sold 15,214 shares of company stock valued at $7,797,595. Insiders own 1.30% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA stock opened at $532.98 on Monday. The company has a market cap of $119.19 billion, a price-to-earnings ratio of 18.78, a PEG ratio of 1.63 and a beta of 1.36. The firm has a fifty day moving average price of $488.01 and a 200-day moving average price of $455.72. HCA Healthcare, Inc. has a 1 year low of $295.00 and a 1 year high of $552.90.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. The business had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The business’s quarterly revenue was up 6.7% on a year-over-year basis. During the same quarter in the prior year, the business posted $6.22 earnings per share. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be given a dividend of $0.78 per share. The ex-dividend date is Tuesday, March 17th. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. HCA Healthcare’s dividend payout ratio is currently 10.15%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.